Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Dynavax's vaccine holds its own against Shingrix in early test
Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s vaccine held its own against GSK’s mainstay.
James Waldron
Aug 21, 2025 8:00am
FDA draft recommends all cancer trials collect OS data
Aug 20, 2025 10:59am
Celldex ends esophageal program despite hitting primary endpoint
Aug 20, 2025 6:42am
Viking hits stormy seas as phase 2 oral obesity data sink stock
Aug 19, 2025 9:44am
Fierce Pharma
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
Reunion's psychedelic reduces postpartum depression in ph. 2
Aug 18, 2025 7:52am